AR015518A1 - Uso de derivados de tiadiazolo piridina para la produccion de un medicamento para el tratamiento de enfermedades que se modulan mediante la inhibicion delas fosfodiesterase(s) - Google Patents
Uso de derivados de tiadiazolo piridina para la produccion de un medicamento para el tratamiento de enfermedades que se modulan mediante la inhibicion delas fosfodiesterase(s)Info
- Publication number
- AR015518A1 AR015518A1 ARP990100622A ARP990100622A AR015518A1 AR 015518 A1 AR015518 A1 AR 015518A1 AR P990100622 A ARP990100622 A AR P990100622A AR P990100622 A ARP990100622 A AR P990100622A AR 015518 A1 AR015518 A1 AR 015518A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- phosphodiesterase
- inhibition
- treatment
- production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Uso de derivados de tiadiazolo piridina para la produccion de un medicamento para el tratamiento de enfermedades que se modulan mediante la inhibicion delas fosfodiesterasa(s), que comprende una cantida eficaz del compuesto de la formula I, donde: X1y X2, idénticos o diferentes, son hidrogeno, un radicalalquilo C1-6, o un átomo halogeno o si los mismos se encuentran en posiciones adyacentes, forman un anillo fenilo fusionado junto con los átomos de carbono quelo transportan; y R es un radical carbocíclico o heterocíclico, saturado o insaturado, que si se desea puede ser mono-o polisustituido con hálogeno, ciano,nitro, alquilo C1-6, haloalquilo C1-6, hidroxilo, alcoxi C1-6, metilendioxi, alquiltio C1-6, haloalquiltio C1-6, amino, alquilamino C1-6, dialquilamino C2-12,pirrolilo, carboxilo, carbamoilo, bencil-hidrosialquilo C1-6, carboxialquilo C2-7, alcoxicarbonil C2-7 -alquilo C1-6, carbamoil-alquilo C1-6, N-hidroxi-N-alquilcarbamoilo C1-6-alquilo C1-6 o alquenilo C2-6, así como también sus sales fisiologicamente tolerables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98102675 | 1998-02-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015518A1 true AR015518A1 (es) | 2001-05-02 |
Family
ID=8231426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990100622A AR015518A1 (es) | 1998-02-17 | 1999-02-16 | Uso de derivados de tiadiazolo piridina para la produccion de un medicamento para el tratamiento de enfermedades que se modulan mediante la inhibicion delas fosfodiesterase(s) |
Country Status (10)
Country | Link |
---|---|
US (1) | US6326378B1 (es) |
EP (1) | EP1054669B9 (es) |
JP (1) | JP3585838B2 (es) |
AR (1) | AR015518A1 (es) |
AU (1) | AU2926099A (es) |
CA (1) | CA2318237A1 (es) |
DE (2) | DE69909592D1 (es) |
ES (1) | ES2203086T3 (es) |
WO (1) | WO1999042089A2 (es) |
ZA (1) | ZA991233B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1193261A1 (en) * | 2000-10-02 | 2002-04-03 | Warner-Lambert Company | New thiadiazoles and their use as phosphodiesterase-7 inhibitors |
EP1348433A1 (en) * | 2002-03-28 | 2003-10-01 | Warner-Lambert Company LLC | Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US7034052B2 (en) * | 2003-03-12 | 2006-04-25 | Celgene Corporation | 7-Amido-isoindolyl compounds and their pharmaceutical uses |
US7564337B2 (en) | 2005-03-03 | 2009-07-21 | Littelfuse, Inc. | Thermally decoupling fuse holder and assembly |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60246389A (ja) * | 1984-05-22 | 1985-12-06 | Nippon Soda Co Ltd | 2−スルホニルイミノ−2H−1,2,4−チアジアゾロ〔2,3−a〕ピリジン誘導体及びその製造法 |
DE4131579A1 (de) * | 1991-09-23 | 1993-03-25 | Boehringer Mannheim Gmbh | Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel |
-
1999
- 1999-02-11 JP JP2000532106A patent/JP3585838B2/ja not_active Expired - Fee Related
- 1999-02-11 EP EP99910217A patent/EP1054669B9/en not_active Expired - Lifetime
- 1999-02-11 US US09/622,325 patent/US6326378B1/en not_active Expired - Fee Related
- 1999-02-11 WO PCT/EP1999/000886 patent/WO1999042089A2/en active IP Right Grant
- 1999-02-11 DE DE69909592A patent/DE69909592D1/de not_active Expired - Fee Related
- 1999-02-11 ES ES99910217T patent/ES2203086T3/es not_active Expired - Lifetime
- 1999-02-11 AU AU29260/99A patent/AU2926099A/en not_active Abandoned
- 1999-02-11 DE DE69909592T patent/DE69909592T4/de not_active Expired - Lifetime
- 1999-02-11 CA CA002318237A patent/CA2318237A1/en not_active Abandoned
- 1999-02-16 ZA ZA9901233A patent/ZA991233B/xx unknown
- 1999-02-16 AR ARP990100622A patent/AR015518A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP3585838B2 (ja) | 2004-11-04 |
DE69909592T4 (de) | 2005-03-24 |
AU2926099A (en) | 1999-09-06 |
JP2002503688A (ja) | 2002-02-05 |
EP1054669B1 (en) | 2003-07-16 |
EP1054669A2 (en) | 2000-11-29 |
WO1999042089A3 (en) | 1999-10-14 |
WO1999042089A9 (en) | 1999-10-28 |
CA2318237A1 (en) | 1999-08-26 |
EP1054669B9 (en) | 2004-09-15 |
ES2203086T3 (es) | 2004-04-01 |
US6326378B1 (en) | 2001-12-04 |
WO1999042089A2 (en) | 1999-08-26 |
DE69909592D1 (de) | 2003-08-21 |
ZA991233B (en) | 1999-08-17 |
DE69909592T2 (de) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV1999000016A (es) | Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv | |
ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
ES2170252T3 (es) | Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde. | |
ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
CO4810373A1 (es) | Compuestos azapoliciclicos condensados con arilo | |
ECSP056246A (es) | DERIVADOS DE PIRROLO [3,4-c]PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA | |
CR10370A (es) | Derivados sustituidos de pirrolo-pirazol inhibidores de quinasa (divisional exp. 7880) | |
AR048642A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento | |
TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
CO4960662A1 (es) | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados | |
AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
AR006906A1 (es) | Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis | |
UY27055A1 (es) | Activadores heteroaromaticos fusionados de la glucoquinasa | |
UY29246A1 (es) | Nuevos compuestos | |
SV1999000009A (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol ref. pg3388/sv | |
ATE302775T1 (de) | Carbolinderivate | |
CR6726A (es) | Compuestos azapoliciclicos condensados con arilo | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
ATE346067T1 (de) | Carbolinderivate | |
HN2009000968A (es) | Compuestos de pirazol y triazol sustituidos como inhibidores de ksp | |
UY27338A1 (es) | Nuevos derivados de ácido sulfónico | |
ES2101858T3 (es) | Derivados de geneserina como inhibidores de colinesterasa. | |
AR028776A1 (es) | Derivados de la pirimidina y su uso para la profilaxis y la terapia de isquemia cerebral | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
AR015518A1 (es) | Uso de derivados de tiadiazolo piridina para la produccion de un medicamento para el tratamiento de enfermedades que se modulan mediante la inhibicion delas fosfodiesterase(s) |